Popular on Rezul
- Philanthropic Coalition Challenges MrBeast
- 11th annual Florida Blueberry Festival April 26 & 27, 2025
- Homeowners Turn to Smart Kitchen Remodeling Companies in Fort Lauderdale
- Tec-Masters to Support In-Space Testing of Honda Regenerative Fuel Cell Technology on the International Space Station
- CriptoAuge's Technological Breakthroughs Paving the Way for Cryptocurrency to Enter the Mainstream
- The Villages Welcomes NexGen Laser Pain and Rehab Centers—Revolutionizing Pain Management with MLS Laser Technology
- Introducing The Lead Nurturer: A Curated Hub for Digital Strategy, Lead Generation, and Business Growth Conversations
- One Home Service Names Perfect Touch Painting as Broward County's #1 Painting Company for 2025
- Spring Special: Say Goodbye to Lice Removal to a Convenient Location in Conroe, TX
- Transform Your Home with Expert Kitchen Remodeling Near Bloomington, MN
Similar on Rezul
- K2 Integrity and Sonata One Partner to Accelerate Capital Raising, Reduce Risk, and Deliver Scalable Advisory Services for Private Fund Managers
- Kemeny, Ramp & Renaud, LLC Welcomes Prominent Trusts and Estates Attorney Gary B. Cornick to Its Firm
- Electives Appoints DraftKings' CPO Linda Aiello to Board Amid Record Quarter
- Co-Creating the Future of ePaper: ZKONG and E Ink at Touch Taiwan 2025
- Webinar Announcement: Mexico's Evolving AML/CFT Environment: FATF Review and FTO Designations
- Emerging Managers Podcast Launches, Highlighting New Players in Venture Capital Outperforming the Status Quo
- Home Run Pest & Termite Control Launches Monthly Mosquito Service to Help Wylie, Plano, and Rockwall Homeowners Reclaim Their Backyards
- T&S and US Conec Ink Global Licensing Deal on MDC Technology to Advance High-Density Optical Interconnects
- Coming Up on "Financial Freedom with Tom Hegna" Retirement Authority Daniel Rondberg from Nation's First Financial
- The Ten News Wins 2025 Ambie Award for Best News Podcast
Phantom Neuro Secures $19M Series A Funding Led by Ottobock to Advance Neural Interface Technology for Prosthetics and Robotics
Rezul News/10699159
AUSTIN, Texas, April 15, 2025 ~ In a major development for the field of neurotechnology, Phantom Neuro has announced an oversubscribed $19 million Series A funding round led by Ottobock, a global leader in prosthetics, orthotics, and exoskeleton technology. The round also includes participation from existing investors such as Breakout Ventures, Draper Associates, LionBird Ventures, Time BioVentures, and Risk and Return, as well as new investors Actual VC, METIS Innovative, e1 Ventures, Jumpspace, MainSheet Ventures, and Brown Advisory.
This latest investment brings Phantom Neuro's total funding to $28 million and marks a significant milestone in the company's mission to bring its Phantom X robotic control platform to patients. The funds will be used to support preclinical testing, complete first-in-human trials, submit regulatory applications, and expand research and development for broader control applications beyond prosthetic limbs.
More on Rezul News
Dr. Connor Glass, Founder and CEO of Phantom Neuro expressed his excitement about Ottobock's involvement in the funding round. He stated that Ottobock's support highlights the growing convergence of neurotechnology with prosthetics and robotics. He also added that Ottobock has been at the forefront of restoring mobility for millions of people for decades and partnering with them will accelerate Phantom X's path to market.
As part of the investment deal, Ottobock will join Phantom Neuro's Board of Directors. This move brings valuable expertise in global prosthetics and exoskeleton markets to support Phantom's commercialization efforts.
Ottobock CEO Oliver Jakobi shared his enthusiasm about the partnership with Phantom Neuro. He stated that their investment reflects their ambition as a MedTech champion to lead the prosthetics market by providing patients with access to the most effective solutions possible. He also expressed his excitement about working with Phantom Neuro to expand access to their groundbreaking technology.
More on Rezul News
This funding comes on the heels of two significant designations received by Phantom X from the U.S. Food and Drug Administration (FDA) - Breakthrough Device Designation and TAP (Targeted Acceleration Pathway) Designation. These designations validate the platform's potential to improve patient outcomes by providing lifelike control of prosthetic limbs and assistive devices, and also help expedite regulatory approvals.
In addition to these achievements, Phantom Neuro's ASCENT study demonstrated that Phantom X achieved an impressive 94% accuracy in decoding real-time gestures across 11 essential hand and wrist movements. This further supports the platform's potential to restore function and independence for individuals with mobility impairments.
With this latest round of funding and support from Ottobock, Phantom Neuro is well-positioned to continue its groundbreaking work in advancing human-machine interfaces and revolutionizing the field of neurotechnology.
This latest investment brings Phantom Neuro's total funding to $28 million and marks a significant milestone in the company's mission to bring its Phantom X robotic control platform to patients. The funds will be used to support preclinical testing, complete first-in-human trials, submit regulatory applications, and expand research and development for broader control applications beyond prosthetic limbs.
More on Rezul News
- MAJOR New release of Krypto500 (ELF-HF) Sigint - COMINT software
- New Build-to-Suit VA Medical Office Facility Coming to Highland Heights, KY
- Felician Sisters of North America Announce Partnership with City of Livonia
- Family Office Real Estate Institute Announces Exclusive Investment Forum
- Fairfield Inn by Marriott Scottsdale Old Town Opens
Dr. Connor Glass, Founder and CEO of Phantom Neuro expressed his excitement about Ottobock's involvement in the funding round. He stated that Ottobock's support highlights the growing convergence of neurotechnology with prosthetics and robotics. He also added that Ottobock has been at the forefront of restoring mobility for millions of people for decades and partnering with them will accelerate Phantom X's path to market.
As part of the investment deal, Ottobock will join Phantom Neuro's Board of Directors. This move brings valuable expertise in global prosthetics and exoskeleton markets to support Phantom's commercialization efforts.
Ottobock CEO Oliver Jakobi shared his enthusiasm about the partnership with Phantom Neuro. He stated that their investment reflects their ambition as a MedTech champion to lead the prosthetics market by providing patients with access to the most effective solutions possible. He also expressed his excitement about working with Phantom Neuro to expand access to their groundbreaking technology.
More on Rezul News
- Liquified Solutions a featured exhibitor at the 2025 Senior Living Executive Conference
- Silva Construction Gives Advice on Home Remodeling Trends for 2025
- BKM's Senior Managing Director of Operations, Susan Rounds, and Associate Director of Design, Koren Mercer, Honored as 2025 Women of Influence
- Pelican Reef Group Announces Grand Opening of New High Point Showroom – IHFC Building H-621 & Event April 27th, 2025
- NaturismRE Launches the 11 Levels of Naturism: A Groundbreaking Framework Guiding the Global Naturist Journey
This funding comes on the heels of two significant designations received by Phantom X from the U.S. Food and Drug Administration (FDA) - Breakthrough Device Designation and TAP (Targeted Acceleration Pathway) Designation. These designations validate the platform's potential to improve patient outcomes by providing lifelike control of prosthetic limbs and assistive devices, and also help expedite regulatory approvals.
In addition to these achievements, Phantom Neuro's ASCENT study demonstrated that Phantom X achieved an impressive 94% accuracy in decoding real-time gestures across 11 essential hand and wrist movements. This further supports the platform's potential to restore function and independence for individuals with mobility impairments.
With this latest round of funding and support from Ottobock, Phantom Neuro is well-positioned to continue its groundbreaking work in advancing human-machine interfaces and revolutionizing the field of neurotechnology.
Filed Under: Business
0 Comments
Latest on Rezul News
- Morgan Porter Earns Broker Associate Title at Parkside Realty Group
- AdvisorVault's Consolidated 17a-4 D3P Service® Full Feature Set Available
- Most Common Car Accidents In America
- Co-Creating the Future of ePaper: ZKONG and E Ink at Touch Taiwan 2025
- New York Times Exposé Vindicates CCHR: ADHD Isn't Biological, Says Watchdog
- HISTORIC FIRST The First Belief System In Human History To Formally Enshrine The Innate Divinity Of The Infant As Civilization's Central Moral Axis
- Stuck in Place? Why Homeowners Are Building Up Instead of Moving Out
- Crafting the Sound of VS Pop™: The Vision of CR Srikanth
- Boston Industrial Solutions, Inc., introduces Rubber and Foam Printing Ink
- LiveDataLink Launches Real Estate Scouting Services in Atlanta for Individuals and Investors
- FeelWise to Exhibit at ATD 2025 International Conference & EXPO in Washington, DC
- Webinar Announcement: Mexico's Evolving AML/CFT Environment: FATF Review and FTO Designations
- Two rare waterfront parcels totaling 4.4 acres in Palmetto hit market
- Damian Redd's "Caught in a Fantasy" Surpasses 100,000 Views on VEVO/YouTube Following Album Reissue
- "May the Fourth Be With You" Epic Star Wars Day Run/Walk in Alexandria, Va
- Museum Hack Presents Hacked Gala: A Rebellious Night of Art, Fashion, and Change at the Met
- Mesa West Capital Originates $134 Million Loan to Refi UGA Student Housing Community
- Artist Séfora Camazano Honored with Prestigious Prize "The New Great Masters in New York"
- MoMojo Records announces posthumous album from Kip London
- Guests Can Save 20 Percent on a Florida Keys Vacation Home Rental with KeysCaribbean's 'Last-Minute Booking Discount'